Quagen Promethazine Syrup​

Quagen Promethazine Syrup is a prescription-grade pharmaceutical liquid manufactured by Quagen Pharmaceuticals, formulated primarily around promethazine hydrochloride, an antihistamine with sedative and anti-nausea properties. In some formulations, Quagen Promethazine Syrup may also be combined with codeine, creating a dual-action medication used for cough suppression and symptom relief in upper respiratory conditions. As a medical product, Quagen Promethazine Syrup is intended for controlled therapeutic use under professional supervision, and it is not designed for casual or unsupervised consumption.

Quagen Syrup

At its core, Quagen Syrup contains promethazine hydrochloride, a compound classified as an H1 receptor antagonist (antihistamine). This means that Quagen Syrup works by blocking histamine activity in the body, reducing symptoms such as allergic reactions, nausea, and irritation in the respiratory tract.

In versions that include codeine, Quagen Promethazine Syrup gains an additional mechanism:

• Promethazine → reduces allergy symptoms and induces mild sedation
• Codeine → suppresses the cough reflex and provides mild analgesic effects

This combination allows Quagen Promethazine Syrup to deliver a multi-layered therapeutic effect, addressing both physical discomfort and the body’s reflex responses, resulting in a more comprehensive treatment profile.

Quagen Codeine Syrup

Quagen Codeine Syrup is typically presented as a flavored liquid solution, often containing sweeteners and flavoring agents to improve palatability. Each standard dose contains a measured concentration of promethazine hydrochloride (commonly 6.25 mg per 5 mL), ensuring controlled and accurate dosing. The syrup may appear in different colors such as purple or green, depending on formulation and additives, though color does not necessarily indicate strength.
These variations are largely cosmetic or related to flavoring, rather than pharmacological differences.